Background Z-drugs are nonbenzodiazepine hypnotics used for sleep
initiation and maintenance; these drugs increase the risk of fall-related
injuries in older adults. The American Geriatrics Society’s Beers
criteria classifies Z-drugs as high-risk and strongly recommends avoiding
prescribing Z-drugs to older adults due to adverse effects. The study objectives
were to determine the prevalence of Z-drug prescribing among Medicare Part D
patients and identify state or specialty-dependent prescribing differences. This
study also aimed to determine prescribing patterns of Z-drugs to Medicare
patients.
Methods Z-drug prescription data was extracted from the Centers for
Medicare and Medicaid Services State Drug Utilization Data for 2018. For all 50
states, the number of prescriptions per 100 Medicare enrollees and days-supply
per prescription was determined. The percentage of total prescriptions
prescribed by each specialty and the average number of prescriptions per
provider within each specialty was also determined.
Results Zolpidem was the most prescribed Z-drug (95.0%).
Prescriptions per 100 enrollees were significantly high in Utah (28.2) and
Arkansas (26.7) and significantly low in Hawaii (9.3) relative to the national
average (17.5). Family medicine (32.1%), internal medicine
(31.4%), and psychiatry (11.7%) made up the largest percentages
of total prescriptions. The number of prescriptions per provider was
significantly high among psychiatrists.
Discussion Contrary to the Beers criteria, Z-drugs are prescribed to older
adults at high rates.
3
Foley DJ,
Monjan A,
Simonsick EM.
et al
Incidence and remission of insomnia among elderly adults: An epidemiologic study
of 6,800 persons over three years. Sleep 1999; 22 Suppl 2 S366-S372
5
Treves N,
Perlman A,
Kolenberg Geron L.
et al.
Z-drugs and risk for falls and fractures in older adults-a systematic review and
meta-analysis. Age Ageing 2018; 47: 201-208
8
2019 American Geriatrics Society Beers Criteria Update
Expert Panel.
American Geriatrics Society 2019 updated AGS Beers Criteria for potentially
inappropriate medication use in older adults. J Am Geriatr Soc 2019; 67: 674-694
9
Pazan F,
Gercke Y,
Weiss C.
et al.
The U.S.-FORTA (Fit for the Aged) list: Consensus validation of a clinical tool
to improve drug therapy in older adults. JAMDA 2020; 21: 439e9-439e13
16
Abed Faghri NM,
Boisvert CM,
Faghri S..
Understanding the expanding role of primary care physicians (PCPs) to primary
psychiatric care physicians (PPCPs): Enhancing the assessment and treatment of
psychiatric conditions. Ment Health Fam Med 2010; 7: 17-25
18
Cosgrove L,
Krimsky S..
A comparison of DSM-IV and DSM-5 panel members' financial associations
with industry: A pernicious problem persists. PLoS Med 2012; 9: e1001190
19
Sirdifield C,
Anthierens S,
Creupelandt H.
et al.
General practitioners' experiences and perceptions of benzodiazepine
prescribing: Systematic review and meta-synthesis. BMC Fam Pract 2013; 14: 191
22
Hojlund M,
Gudmundsson LS,
Anderson JH.
et al.
Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries
between 2000 and 2020. Basic Clin Pharmacol Toxicol 2022; 32: 60-70
23
Sateia MJ,
Buysse DJ,
Krystal AD.
et al.
Clinical practice guideline for the pharmacologic treatment of chronic insomnia
in adults: An American Academy of Sleep Medicine clinical practice
guideline. J Clin Sleep Med 2017; 13: 307-349